Introduction: The global incidence of benign prostatic hyperplasia (BPH) is rising, with bacterial causes of lower urinary tract symptoms (LUTS) being a common factor contributing to complications in these patients.
Aim: To identify the prevalence of bacteriuria and treatment response in patients with symptomatic BPH.
Materials And Methods: This 1-year prospective study included all patients presenting with LUTS due to BPH who met the inclusion criteria.